Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 266,559 | 298,418 | 79,880 | 76,844 | 72,564 |
| Marketable Securities | 47,394 | 59,933 | 63,633 | 118,626 | 171,108 |
| Receivables | 25 | 772 | N/A | N/A | N/A |
| Inventories | 5,646 | 4,076 | N/A | N/A | N/A |
| TOTAL | $323,641 | $367,820 | $149,077 | $202,236 | $250,531 |
| Non-Current Assets | |||||
| PPE Net | 26,540 | 27,506 | 28,604 | 28,713 | 29,414 |
| Investments And Advances | 4,127 | 13,256 | 14,661 | 5,038 | 6,584 |
| Other Non-Current Assets | 10,978 | 11,470 | 12,027 | 12,411 | 12,247 |
| TOTAL | $41,645 | $52,232 | $55,292 | $46,162 | $48,245 |
| Total Assets | $365,286 | $420,052 | $204,369 | $248,398 | $298,776 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,107 | 13,952 | 13,882 | 11,941 | 14,086 |
| Accrued Expenses | 25,468 | 29,128 | 31,286 | 29,480 | 27,083 |
| Other current liabilities | 27 | 24 | 23 | 21 | 20 |
| TOTAL | $43,001 | $45,419 | $47,448 | $43,605 | $43,211 |
| Non-Current Liabilities | |||||
| Long Term Debt | 131,462 | 128,250 | 41,028 | 39,782 | 38,526 |
| Other Non-Current Liabilities | 10,965 | 11,336 | 11,869 | 12,319 | 12,065 |
| TOTAL | $142,427 | $139,586 | $52,897 | $52,101 | $50,591 |
| Total Liabilities | $185,428 | $185,005 | $100,345 | $95,706 | $93,802 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,450 | 65,251 | 65,042 | 63,300 | 62,669 |
| Common Shares | 7 | 7 | 6 | 6 | 6 |
| Retained earnings | -880,356 | -811,112 | -724,680 | -657,782 | -593,326 |
| Other shareholders' equity | 239 | 163 | 80 | 140 | 236 |
| TOTAL | $179,858 | $235,047 | $104,024 | $152,692 | $204,974 |
| Total Liabilities And Equity | $365,286 | $420,052 | $204,369 | $248,398 | $298,776 |